About INVIVYD, INC.
Invivyd is a biopharmaceutical company focused on developing antibody-based therapies to address evolving viral threats, particularly for the prevention and treatment of serious infectious diseases such as COVID-19 and influenza.
Development of monoclonal antibody candidates for prevention and treatment of serious viral diseasesProprietary integrated technology platform for assessing, monitoring, developing, and adapting antibodiesViral surveillance and predictive modeling capabilitiesAdvanced antibody engineering techniques
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INVIVYD, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.